| ŠVESTKA, Jaromír, Oldřich SYNEK a Alexandra ŽOURKOVÁ. Olanzapine versus risperidone in first-episode schizophrenic and schizophorm disorders:a double-blind comparison. European Neuropsychopharmacology. 2003, roč. 13, Suppl.4, s. S291, 1 s. ISSN 0924-977X. |
Další formáty:
BibTeX
LaTeX
RIS
@article{489038,
author = {Švestka, Jaromír and Synek, Oldřich and Žourková, Alexandra},
article_number = {Suppl.4},
keywords = {schzophrenia-olanzapine-risperidone-efficacy-side effects},
language = {eng},
issn = {0924-977X},
journal = {European Neuropsychopharmacology},
title = {Olanzapine versus risperidone in first-episode schizophrenic and schizophorm disorders:a double-blind comparison},
volume = {13},
year = {2003}
}
TY - JOUR
ID - 489038
AU - Švestka, Jaromír - Synek, Oldřich - Žourková, Alexandra
PY - 2003
TI - Olanzapine versus risperidone in first-episode schizophrenic and schizophorm disorders:a double-blind comparison
JF - European Neuropsychopharmacology
VL - 13
IS - Suppl.4
SP - S291
EP - S291
SN - 0924977X
KW - schzophrenia-olanzapine-risperidone-efficacy-side effects
N2 - In double-blind randomized trial olanzapine was more suitable antipsychotic for the treatment of first-episode psychoses for the greater final improvement, better reduction of negative symptoms a fewer extrapyramidal side -effects and hyperprolactinemia than risperidone
ER -
ŠVESTKA, Jaromír, Oldřich SYNEK a Alexandra ŽOURKOVÁ. Olanzapine versus risperidone in first-episode schizophrenic and schizophorm disorders:a double-blind comparison. \textit{European Neuropsychopharmacology}. 2003, roč.~13, Suppl.4, s.~S291, 1 s. ISSN~0924-977X.
|
